Showing results (1-10 of 232) with videos related to
Sort By:
Pageof 24
Journal of Psychopharmacology (Oxford, England)|January 9, 2015
Functional brain connectivity phenotypes for schizophrenia drug discoveryNeil Dawson, Brian J Morris, Judith A PrattSchizophrenia Bulletin|November 25, 2011
Subanaesthetic ketamine treatment alters prefrontal cortex connectivity with thalamus and ascending subcortical systemsNeil Dawson, Brian J Morris, Judith A PrattNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 5, 2014
Subanesthetic ketamine treatment promotes abnormal interactions between neural subsystems and alters the properties of functional brain networksNeil Dawson, Martin McDonald, Desmond J Higham, et al.Cerebral Cortex (New York, N.Y. : 1991)|October 20, 2012
Sustained NMDA receptor hypofunction induces compromised neural systems integration and schizophrenia-like alterations in functional brain networksNeil Dawson, Xiaolin Xiao, Martin McDonald, et al.Schizophrenia Bulletin|September 3, 2010
Modafinil reverses phencyclidine-induced deficits in cognitive flexibility, cerebral metabolism, and functional brain connectivityNeil Dawson, Rhiannon J Thompson, Allan McVie, et al.Journal of Psychopharmacology (Oxford, England)|January 15, 2015
The thalamic reticular nucleus: a functional hub for thalamocortical network dysfunction in schizophrenia and a target for drug discoveryJudith A Pratt, Brian J MorrisFrontiers in Psychiatry|February 11, 2025
Maximising translational value of the Iowa gambling task in preclinical studies through the use of the rodent touchscreenJudith A Pratt, Brian J MorrisJournal of Psychopharmacology (Oxford, England)|October 28, 2025
Targeting disrupted networks in schizophrenia: Can muscarinic drugs make a fundamental difference?Judith A Pratt, Brian J MorrisCurrent Topics in Behavioral Neurosciences|May 4, 2018
Deconstructing Schizophrenia: Advances in Preclinical Models for Biomarker IdentificationJudith A Pratt, Brian Morris, Neil DawsonBMC Systems Biology|May 18, 2011
Exploring metabolic pathway disruption in the subchronic phencyclidine model of schizophrenia with the Generalized Singular Value DecompositionXiaolin Xiao, Neil Dawson, Lynsey Macintyre, et al.Pageof 24